Spatial Transcriptomics
APAC · 3 shared keywords
APAC Whole Genome Sequencing Market Industry Trends and Forecast to 2034: Segmented by (Product, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Overview
APAC · 2024–2034 · estimates
Market Dashboard
Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Estimate 2024
$575.1 Mn
Estimated value
Estimate 2025
$684.4 Mn
19.7% of the global market
Projected 2034
$3.28 Bn 378.5%
Adds $2.59 Bn over 9 forecast years
CAGR 2025–2034
19.0%
Faster than 82% of 180 Pharmaceuticals markets here
Key players
5
Companies profiled
- APAC is 19.66% of the global market.
- Among regions, the largest is North America at $1.76 Bn.
- Fastest growing: Africa at 19.4% a year.
- APAC ranks 2nd of 6 by size among regions.
Market size projection
APACSource: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
Value added each year
$2.59 Bn total, 2026–2034
Year-by-year market size, 2024–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $575.1 Mn | — | — |
| 2025 (base) | $684.4 Mn | +$109.3 Mn | — |
| 2026 (forecast) | $814.4 Mn | +$130.0 Mn | +19% |
| 2027 (forecast) | $969.2 Mn | +$154.7 Mn | +41.6% |
| 2028 (forecast) | $1.15 Bn | +$184.1 Mn | +68.5% |
| 2029 (forecast) | $1.37 Bn | +$219.1 Mn | +100.5% |
| 2030 (forecast) | $1.63 Bn | +$260.8 Mn | +138.6% |
| 2031 (forecast) | $1.94 Bn | +$310.3 Mn | +184% |
| 2032 (forecast) | $2.31 Bn | +$369.3 Mn | +237.9% |
| 2033 (forecast) | $2.75 Bn | +$439.4 Mn | +302.1% |
| 2034 (forecast) | $3.28 Bn | +$522.9 Mn | +378.5% |
Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
Same market worldwide
By geography
- Global $3.48 Bn
- North America $1.76 Bn
-
US
$1.36 Bn
- APAC (this report) $684.4 Mn
- Europe $610.8 Mn
-
Canada
$299.6 Mn
-
China
$251.0 Mn
-
Japan
$238.8 Mn
-
Germany
$138.0 Mn
- Latin America $138.5 Mn
- Middle East $132.8 Mn
-
Italy
$92.0 Mn
-
Brazil
$89.7 Mn
-
UK
$83.4 Mn
-
France
$80.1 Mn
-
Ecuador
$67.2 Mn
-
India
$68.6 Mn
-
Spain
$63.3 Mn
-
Saudi Arabia
$60.8 Mn
-
Mexico
$50.7 Mn
- Africa $49.8 Mn
-
New Zealand
$39.2 Mn
-
Russia
$38.5 Mn
-
Australia
$38.9 Mn
-
South Africa
$24.6 Mn
-
UAE
$15.7 Mn
-
Egypt
$11.3 Mn
-
Philippines
$7.9 Mn
-
Hong Kong
$6.2 Mn
-
Malaysia
$5.5 Mn
-
Thailand
$4.5 Mn
-
Singapore
$4.1 Mn
-
Kenya
$2.1 Mn
The APAC Whole Genome Sequencing Market Analysis Executive Summary
Whole genome sequencing reads a person's entire DNA code, used for rare disease diagnosis, cancer, research and population health.
Key segments of the whole Genome Sequencing market include product (Instruments, Consumables and Services) and application (Rare Disease Diagnosis, Oncology and Population Genomics).
APAC Whole Genome Sequencing Market Dynamics
Market Growth Drivers
The falling cost of DNA sequencing, more targeted medicines, large national genome programmes and growing use of genetic results in everyday care are driving the whole Genome Sequencing market.
Opportunity
Routine use of genomics in screening, pharmacy and primary care gives the whole Genome Sequencing market large room to grow.
Market Restraints
Data privacy concerns, limited reimbursement for some tests, shortages of genetic counsellors and complex data analysis hold back the whole Genome Sequencing market.
Competitive Landscape for Whole Genome Sequencing Market in APAC
The whole Genome Sequencing market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Key Players
Healthcare Policies and Regulatory Landscape for Whole Genome Sequencing Market in APAC
Policy changes and Reimbursement scenario
Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for whole Genome Sequencing. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in APAC.
Beyond the market numbers
Research, trials and patients
What doctors and scientists are doing in Whole Genome Sequencing right now, from free public sources.
Latest research 29,479 papers since 2021 (worldwide)
- Genomic profiling of maternal Streptococcus agalactiae reveals prophage-associated resistance and comparative characterization of anovaginal and respiratory isolates. Microbial pathogenesis, 2026
- Prevalence of new and repurposed drug resistance and associated genetic variants among rifampicin-resistant Mycobacterium tuberculosis in Shenzhen, China: a population-based study. International journal of antimicrobial agents, 2026
- Genomic Insights into Early Catheter-Associated UTIs in a Clinical Setting: High-Risk Clones, Hidden Diversity and Limited Catheter-Urine Genomic Divergence. The Journal of hospital infection, 2026
- Genomic and phenotypic characterization of four foodborne Vibrio harveyi: Insights into antimicrobial resistance, secretion systems, and ecological fitness. International journal of food microbiology, 2026
- The hidden burden of structural variants in neurodegenerative and neuromuscular disorders. Scientific reports, 2026
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
Public data, with sources
Whole Genome Sequencing in context
Questions, answered with public data
- How much research is published on Whole Genome Sequencing?
- PubMed lists 29,479 papers added since January 2021 that match this market, worldwide.[1]
[1] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.